Understanding Urokinase (CAS 9039-53-6): A Key Player in Fibrinolysis
At NINGBO INNO PHARMCHEM CO.,LTD., we are dedicated to providing high-quality biochemicals that drive scientific advancement. Among our essential offerings is Urokinase, a remarkable enzyme with the CAS number 9039-53-6. This article aims to shed light on what makes Urokinase a cornerstone in both clinical practice and cutting-edge research, focusing on its unique properties and extensive applications.
Urokinase, often abbreviated as UK, is a serine protease enzyme that plays a pivotal role in the fibrinolytic system. Its primary function is to catalyze the conversion of plasminogen to plasmin. Plasmin is the active enzyme responsible for degrading fibrin, the main structural component of blood clots. This direct activation of plasminogen by Urokinase is a key differentiator from other fibrinolytic agents, making it a potent tool for dissolving thrombi. The scientific community extensively studies the Urokinase enzyme mechanism to harness its therapeutic potential.
Historically, Urokinase has been extracted from human urine or cultured human kidney cells. This biological origin contributes to its favorable properties, such as being non-antigenic, which reduces the risk of allergic reactions in patients compared to animal-derived or microbial products. This characteristic makes it a preferred choice for many clinical applications where patient safety is paramount. The Urokinase production process is carefully controlled to ensure high purity and consistent activity.
The clinical uses of Urokinase are well-established, particularly in the treatment of thromboembolic disorders. It is employed to dissolve blood clots in conditions like deep vein thrombosis (DVT), pulmonary embolism (PE), and myocardial infarction. Its ability to restore blood flow in occluded vessels makes it a life-saving medication. For those looking to buy Urokinase online for research or specialized applications, ensuring a reputable supplier is crucial for product quality and efficacy.
Beyond its clinical utility, Urokinase is an indispensable resource in medical research. It is widely used in laboratory settings for various studies, including the development of animal models of thrombosis and other vascular diseases. Researchers frequently utilize Urokinase for animal modeling to investigate disease pathogenesis and to test the efficacy of new antithrombotic drugs. The availability of Urokinase CAS 9039-53-6 for purchase facilitates these vital research endeavors.
The demand for high-quality Urokinase remains consistent, driven by both pharmaceutical manufacturing and academic research. NINGBO INNO PHARMCHEM CO.,LTD. is committed to meeting this demand by providing a reliable source of Urokinase, adhering to stringent quality control measures. Our focus is on supporting the scientific community with the materials needed to advance healthcare and understanding of complex biological processes.
Perspectives & Insights
Silicon Analyst 88
“This characteristic makes it a preferred choice for many clinical applications where patient safety is paramount.”
Quantum Seeker Pro
“The Urokinase production process is carefully controlled to ensure high purity and consistent activity.”
Bio Reader 7
“The clinical uses of Urokinase are well-established, particularly in the treatment of thromboembolic disorders.”